文献速递肺外科

微创肺叶切除术的应用趋势、结局与费用

Utilization Trends, Outcomes, and Cost in Minimally Invasive Lobectomy.
PubMed 文献 · Ann Thorac Surg · 2019-08-07

该研究基于佛罗里达州住院患者数据库2008至2014年数据,比较开放、VATS和RATS肺叶切除术的结局与费用。共纳入15038例,RATS占比从2008年不足1%增至2014年25%。VATS和RATS均与较低住院死亡率相关,VATS费用低2%,RATS费用高13%。

要点

  • VATS和RATS肺叶切除术较开胸降低住院死亡率。
  • RATS肺叶切除术占比从2008年不足1%快速增至2014年25%。
  • VATS费用较开胸低2%,RATS费用较开胸高13%。

核心结论

  • 微创入路与开胸肺叶切除术相比结局更优,但仅RATS应用快速增长。
  • 尽管费用增加,RATS肺叶切除术似乎是可行的微创选择。

研究设计与样本

  • 基于佛罗里达州住院患者数据库2008至2014年的回顾性队列研究。
  • 共纳入15038例择期肺叶切除术患者,采用分层 logistic 和线性回归模型比较结局与费用。

主要发现

  • 8501例(56.5%)行开放手术,4608例(30.7%)行VATS,1929例(12.8%)行RATS。
  • RATS肺叶切除术占比从2008年不足1%增至2014年25%。

关键数值与推荐

  • VATS住院死亡率OR 0.69(95%CI 0.50-0.94)。

临床怎么用

  • VATS和RATS肺叶切除术可作为开胸手术的微创替代方案。
  • 选择RATS时需权衡其临床获益与较高的住院费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive lobectomy is associated with decreased morbidity and length of stay. However, there have been few published analyses using recent, population-level data to compare clinical outcomes and cost by surgical approach, inclusive of robotic-assisted thoracoscopic surgery (RATS). The objective of this study was to compare outcomes and hospitalization costs among patients undergoing open, video-assisted thoracoscopic surgery (VATS) and RATS lobectomy. METHODS: We identified patients who underwent elective lobectomy in the Healthcare Cost and Utilization Project Florida State Inpatient Database (2008 to 2014). Hierarchical logistic and linear regression models were used to compare in-hospital mortality, postoperative complications, prolonged length of stay, 30-day readmissions, and index hospitalization costs among cohorts. RESULTS: We identified 15,038 patients, of whom 8501 (56.5%), 4608 (30.7%), and 1929 (12.8%) underwent open, VATS, and RATS lobectomy, respectively. Robotic-assisted lobectomies comprised less than 1% of total lobectomy volume in 2008, and grew to 25% of lobectomy volume by 2014. Both VATS and RATS lobectomies were associated with decreased in-hospital mortality compared to thoracotomy (VATS odds ratio 0.69, 95% confidence interval, 0.50 to 0.94; RATS odds ratio 0.58, 95% confidence interval, 0.35 to 0.96; P = .016). After adjusting for patient age, sex, income, comorbidities, and hospital teaching status, VATS lobectomy was 2% less expensive (P = .007) and robotic-assisted lobectomy was 13% more expensive (P < .001) than the open approach. CONCLUSIONS: Minimally invasive approaches were associated to improved clinical outcomes compared with open lobectomy. However, only robotic-assisted lobectomy has had rapid growth in utilization. Despite additional cost, RATS lobectomy appears to provide a viable minimally invasive alternative for general thoracic procedures.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Subramanian MP, Liu J, Chapman WC, et al. Utilization Trends, Outcomes, and Cost in Minimally Invasive Lobectomy. Ann Thorac Surg. 2019. PMID: 31400324. doi:10.1016/j.athoracsur.2019.06.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。